The FDA said it would allow for a third primary series dose for certain immunocompromised children ages 5 through 11. (Pfizer) Share this article:FacebookTwitterLinkedInPinterestMorePrint
Justice Clarence Thomas and the Conservative Supreme Court Have Fanned the Flames of Racism in America Jun 27, 2022 Cincinnati Herald